The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
Published Sep 1, 2016 · M. Dragoman, M. E. Gaffield
Contraception
35
Citations
0
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayDMPA-SC is generally safe for use in women with age, obesity, endometriosis, or HIV, and appears to be therapeutically equivalent to DMPA-IM.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.